A recent study showed that ANXA7, having different roles in autophagy, tumor suppression, and exocytosis [28–30], was negative regulation of PC-PLC in HUVECs and suggested that ANXA7/PC-PLC signaling pathway may present a novel target to treat atherosclerosis [17]. Here, ANXA7 is linked to atherosclerosis.